166 related articles for article (PubMed ID: 34684792)
1. p53 Antibodies as a Diagnostic Marker for Cancer: A Meta-Analysis.
Sobhani N; Roviello G; D'Angelo A; Roudi R; Neeli PK; Generali D
Molecules; 2021 Oct; 26(20):. PubMed ID: 34684792
[No Abstract] [Full Text] [Related]
2. Assessment of the potential diagnostic value of serum p53 antibody for cancer: a meta-analysis.
Zhang J; Xu Z; Yu L; Chen M; Li K
PLoS One; 2014; 9(6):e99255. PubMed ID: 24911057
[TBL] [Abstract][Full Text] [Related]
3. Potential diagnostic value of serum p53 antibody for detecting esophageal cancer: a meta-analysis.
Zhang J; Xv Z; Wu X; Li K
PLoS One; 2012; 7(12):e52896. PubMed ID: 23285221
[TBL] [Abstract][Full Text] [Related]
4. Serum p53 antibody: useful for detecting gastric cancer but not for predicting prognosis after surgery.
Oshima Y; Suzuki T; Yajima S; Nanami T; Shiratori F; Funahashi K; Shimada H
Surg Today; 2020 Nov; 50(11):1402-1408. PubMed ID: 32458231
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of anti-p53 and anti-KRas circulating antibodies in esophageal cancer patients treated with chemoradiotherapy.
Blanchard P; Quero L; Pacault V; Schlageter MH; Baruch-Hennequin V; Hennequin C
BMC Cancer; 2012 Mar; 12():119. PubMed ID: 22448886
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of serum p53 antibodies in patients with resected non-small cell lung cancer.
Laudanski J; Burzykowski T; Niklinska W; Chyczewski K; Furman M; Niklinski J
Lung Cancer; 1998 Dec; 22(3):191-200. PubMed ID: 10048472
[TBL] [Abstract][Full Text] [Related]
7. p53 Antibodies in the sera of patients with various types of cancer: a review.
Soussi T
Cancer Res; 2000 Apr; 60(7):1777-88. PubMed ID: 10766157
[TBL] [Abstract][Full Text] [Related]
8. Presence of serum anti-p53 antibodies is associated with pleural effusion and poor prognosis in lung cancer patients.
Lai CL; Tsai CM; Tsai TT; Kuo BI; Chang KT; Fu HT; Perng RP; Chen JY
Clin Cancer Res; 1998 Dec; 4(12):3025-30. PubMed ID: 9865916
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of serum and ascitic p53 autoantibodies in epithelial ovarian carcinoma.
Abendstein B; Marth C; Müller-Holzner E; Widschwendter M; Daxenbichler G; Zeimet AG
Cancer; 2000 Mar; 88(6):1432-7. PubMed ID: 10717627
[TBL] [Abstract][Full Text] [Related]
10. Anti-p53 autoantibody in blood as a diagnostic biomarker for colorectal cancer: A meta-analysis.
Liu S; Tan Q; Song Y; Shi Y; Han X
Scand J Immunol; 2020 Feb; 91(2):e12829. PubMed ID: 31536647
[TBL] [Abstract][Full Text] [Related]
11. Clinical Significance of Serum p53 Antibody in the Early Detection and Poor Prognosis of Gastric Cancer.
Kunizaki M; Fukuda A; Wakata K; Tominaga T; Nonaka T; Miyazaki T; Matsumoto K; Sumida Y; Hidaka S; Yasutake T; Sawai T; Hamamoto R; Nanashima A; Nagayasu T
Anticancer Res; 2017 Apr; 37(4):1979-1984. PubMed ID: 28373470
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies against P53 protein in patients with transitional cell carcinoma of the bladder.
Sanchez-Carbayo M; Chulia MT; Niveiro M; Aranda I; Mira A; Soria F
Anticancer Res; 1999; 19(4C):3531-7. PubMed ID: 10629648
[TBL] [Abstract][Full Text] [Related]
13. Alterations of TP53 are associated with a poor outcome for patients with hepatocellular carcinoma: evidence from a systematic review and meta-analysis.
Liu J; Ma Q; Zhang M; Wang X; Zhang D; Li W; Wang F; Wu E
Eur J Cancer; 2012 Oct; 48(15):2328-38. PubMed ID: 22459764
[TBL] [Abstract][Full Text] [Related]
14. Clinical utility of anti-p53 auto-antibody: systematic review and focus on colorectal cancer.
Suppiah A; Greenman J
World J Gastroenterol; 2013 Aug; 19(29):4651-70. PubMed ID: 23922463
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of high serum p53 antibody titers in patients with esophageal squamous cell carcinoma.
Suzuki T; Yajima S; Ishioka N; Nanami T; Oshima Y; Washizawa N; Funahashi K; Otsuka S; Nemoto T; Shimada H
Esophagus; 2018 Oct; 15(4):294-300. PubMed ID: 29959634
[TBL] [Abstract][Full Text] [Related]
16. Serum p53 antibodies as a prognostic indicator in oral squamous cell carcinoma.
Yamazaki Y; Chiba I; Ishikawa M; Satoh C; Notani K; Ohiro Y; Totsuka Y; Mizuno S; Kitagawa Y
Odontology; 2008 Jul; 96(1):32-7. PubMed ID: 18661202
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Role of Serum Antibody Immunity to p53 Oncogenic Protein in Ovarian Cancer: A Systematic Review and a Meta-Analysis.
Garziera M; Montico M; Bidoli E; Scalone S; Sorio R; Giorda G; Lucia E; Toffoli G
PLoS One; 2015; 10(10):e0140351. PubMed ID: 26451959
[TBL] [Abstract][Full Text] [Related]
18. Serum anti-p53 antibodies and p53 protein status in the sera and tumors from bladder cancer patients.
Morita T; Tachikawa N; Kumamaru T; Nukui A; Ikeda H; Suzuki K; Tokue A
Eur Urol; 2000 Jan; 37(1):79-84. PubMed ID: 10671790
[TBL] [Abstract][Full Text] [Related]
19. Serum p53 antibody as a potential tumor marker in extrahepatic cholangiocarcinoma.
Okada R; Shimada H; Otsuka Y; Tsuchiya M; Ishii J; Katagiri T; Maeda T; Kubota Y; Nemoto T; Kaneko H
Surg Today; 2017 Dec; 47(12):1492-1499. PubMed ID: 28508195
[TBL] [Abstract][Full Text] [Related]
20. Clinical Value of Serum p53 Antibody in the Diagnosis and Prognosis of Colorectal Cancer.
Kunizaki M; Sawai T; Takeshita H; Tominaga T; Hidaka S; To K; Miyazaki T; Hamamoto R; Nanashima A; Nagayasu T
Anticancer Res; 2016 Aug; 36(8):4171-5. PubMed ID: 27466527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
